Keros Therapeutics, Inc. (KROS)
10.50
-0.49
(-4.46%)
USD |
NASDAQ |
May 15, 16:00
10.51
+0.01
(+0.10%)
After-Hours: 20:00
Keros Therapeutics Profit Margin (Quarterly) : -6.46K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 45.29% |
| PTC Therapeutics, Inc. | -1.03% |
| Insmed, Inc. | -53.46% |
| United Therapeutics Corp. | 35.18% |
| Enanta Pharmaceuticals, Inc. | -76.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.61% |
| Return on Assets | -14.48% |
| Return on Invested Capital | -15.12% |
| Gross Profit Margin (Quarterly) | -9.81% |
| Operating Margin (Quarterly) | -7.05K% |
| Return on Net Operating Assets | -197.1% |